Disease Markers
Volume 20, Issue 2 309391 pp. 97-102
Article
Open Access

Development Tracks for Cancer Prevention Markers

Stuart G. Baker, 

Corresponding Author

Stuart G. Baker

Biometry Research Group Division of Cancer Prevention National Cancer Institute Bethesda MD, USA , cancer.gov

Search for more papers by this author
Barnett S. Kramer, 

Barnett S. Kramer

Office of Disease Prevention National Institutes of Health Bethesda MD, USA , nih.gov

Search for more papers by this author
Philip C. Prorok, 

Philip C. Prorok

Biometry Research Group Division of Cancer Prevention National Cancer Institute Bethesda MD, USA , cancer.gov

Search for more papers by this author
First published: 10 June 2013
https://doi.org/10.1155/2004/309391
Citations: 10

Abstract

We provide a general framework for describing various roles for biomarkers in cancer prevention research (early detection, surrogate endpoint, and cohort identification for primary prevention) and the phases in their evaluation.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.